Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Am Soc Nephrol ; 14(11): 2790-800, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14569089

RESUMO

Glomerular capillary hypertension is an important determinant of glomerulosclerosis in rats with subtotal renal ablation. Dietary supplementation with L-arginine increases renal nitric oxide (NO) production and limits glomerular injury in this model, and early benefits are seen without altered glomerular capillary pressure. In an in vitro model of hemodynamically mediated signaling, the authors have reported that subjecting MC to cyclic stretch/relaxation activates the mitogen-activated protein kinase p42/44 (Erk) cascade and that NO and cyclic GMP abrogate stretch-induced Erk activation by inducing actin cytoskeletal disassembly. The actin cytoskeleton is regulated by the Rho family of GTPases, including RhoA; therefore, the authors examined the role of RhoA in stretch-induced Erk activation and as an NO target. In primary rat MC subjected to cyclic mechanical strain, RhoA activity was maximally increased (2.4-fold) after 1 min of stretch, and Erk activation temporally followed. The Rho-kinase inhibitor Y-27632 attenuated Erk activation in a dose-dependent manner and prevented stretch-induced actin stress fiber formation. The NO donors S-nitroso-N-acetylpenicillamine and cGMP both inhibited stretch-induced RhoA and Erk activation and stress fiber formation. Infection of MC with the RhoA mutant RhoA-Ala188, which is resistant to NO-dependent phosphorylation, abrogated the effects of NO and cGMP on stretch-induced Erk activation and stress fiber formation. The authors conclude that the early activation of RhoA is essential for stretch-induced actin stress fiber formation and Erk activation in MC, events which are prevented by NO and cGMP through their action on RhoA. Inhibition of RhoA may thus be a new approach to the prevention of hemodynamically mediated glomerular injury.


Assuntos
Actinas/biossíntese , Mesângio Glomerular/enzimologia , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Óxido Nítrico/fisiologia , Proteína rhoA de Ligação ao GTP/metabolismo , Animais , Técnicas de Cultura de Células , Ratos , Ratos Sprague-Dawley , Estresse Mecânico
2.
J Biol Chem ; 278(32): 30317-27, 2003 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-12738777

RESUMO

Hyperhomocysteinemia is an independent risk factor for cardiovascular disease and accelerates atherosclerosis in apoE-/- mice. Despite the observations that homocysteine causes endoplasmic reticulum (ER) stress and programmed cell death (PCD) in cultured human vascular endothelial cells, the cellular factors responsible for this effect and their relevance to atherogenesis have not been completely elucidated. We report here that homocysteine induces the expression of T-cell death-associated gene 51 (TDAG51), a member of the pleckstrin homology-related domain family, in cultured human vascular endothelial cells. This effect was observed for other ER stress-inducing agents, including dithiothreitol and tunicamycin. TDAG51 expression was attenuated in homozygous A/A mutant eukaryotic translation initiation factor 2 alpha mouse embryonic fibroblasts treated with homocysteine or tunicamycin, suggesting that ER stress-induced phosphorylation of eukaryotic translation initiation factor 2 alpha is required for TDAG51 transcriptional activation. Transient overexpression of TDAG51 elicited significant changes in cell morphology, decreased cell adhesion, and promoted detachment-mediated PCD. In support of these in vitro findings, TDAG51 expression was increased and correlated with PCD in the atherosclerotic lesions from apoE-/- mice fed hyperhomocysteinemic diets, compared with mice fed a control diet. Collectively, these findings provide evidence that TDAG51 is induced by homocysteine, promotes detachment-mediated PCD, and contributes to the development of atherosclerosis observed in hyperhomocysteinemia.


Assuntos
Apoptose , Arteriosclerose/patologia , Homocisteína/química , Hiper-Homocisteinemia/patologia , Fatores de Transcrição/química , Animais , Northern Blotting , Adesão Celular , Núcleo Celular/metabolismo , Células Cultivadas , Clonagem Molecular , Cruzamentos Genéticos , DNA Complementar/metabolismo , Retículo Endoplasmático/metabolismo , Endotélio Vascular/citologia , Técnica Indireta de Fluorescência para Anticorpo , Perfilação da Expressão Gênica , Biblioteca Gênica , Homocisteína/metabolismo , Humanos , Hiper-Homocisteinemia/complicações , Marcação In Situ das Extremidades Cortadas , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Fosforilação , Ligação Proteica , Estrutura Terciária de Proteína , RNA Mensageiro/metabolismo , Frações Subcelulares , Fatores de Tempo , Distribuição Tecidual , Fatores de Transcrição/metabolismo , Ativação Transcricional , Transfecção , Tunicamicina/farmacologia , Veias Umbilicais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA